PGR and breast carcinoma: It is also known that P4-PR induces receptor activator of the nuclear factor kappa-B ligand (RANKL) paracrine signaling from luminal cells to promote mammary epithelial proliferation and carcinogenesis (110, 111) suggesting PR as an ideal target for breast cancer prevention.